title: Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trials.
authors.affiliation: Department of Haematology, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. miles.prince@petermac.org
authors.forename: H Miles
authors.initials: HM
authors.lastname: Prince
mesh_terms: D005260:Female; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D000077767:Panobinostat
chemical_list: D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D007211:Indoles; D000077767:Panobinostat